Neurotrophic Factors and Retinal Ganglion Cell Survival In Vitro
Principal Investigator
David Hicks, PhD
French National Institute of Health and Medical Research
Strasbourg, France
About the Research Project
Program
Award Type
Standard
Award Amount
$70,000
Active Dates
April 01, 2002 - September 30, 2004
Grant ID
G2002015
Summary
Certain neurotrophic factors (NTF) have been implicated in retinal ganglion cell (RGC) development and survival and may be involved in RGC loss during glaucoma. Dr. Hicks is screening for the expression of specific NTFs (the neurotrophins and the fibroblast growth factors) and their receptors in primary cultures of RGCs from porcine and human retinas and in post-mortem human adult eye tissue. He will determine which ligand/receptors have the ability to stimulate RGC survival and neurite regrowth and also identify the signaling pathways involved. He will also examine fixed human tissue from normal and glaucomatous eyes. It is believed that the determination of which NTFs influence the survival of RGCs will have a significant impact on the treatment of glaucoma.
Grants
Related Grants
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Haiyan Li, PhD
National Glaucoma Research
Pressure-Induced Axon Damage and Its Link to Glaucoma-Related Vision Loss
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Bingrui Wang, PhD
Pressure-Induced Axon Damage and Its Link to Glaucoma-Related Vision Loss
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Bingrui Wang, PhD
National Glaucoma Research
Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Mengya Zhao, PhD
Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Mengya Zhao, PhD